Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents. [PDF]
Kamei K +7 more
europepmc +1 more source
Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis. [PDF]
Liu J, Li X, Huang T, Xu G.
europepmc +1 more source
Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents. [PDF]
Picchianti-Diamanti A +4 more
europepmc +1 more source
Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis. [PDF]
Iryaningrum MR +4 more
europepmc +1 more source
Efficacy and safety of nine immunosuppressive agents for primary focal segmental glomerulosclerosis in adults: a pairwise and network meta-analysis. [PDF]
Zhu Y, Chen B, Xu G.
europepmc +1 more source
Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID-19 Vaccination Antibody Response. [PDF]
Petri M +8 more
europepmc +1 more source
Immunosuppressive agents for treating IgA nephropathy.
M. Vecchio +8 more
semanticscholar +1 more source
Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients. [PDF]
Job KM +9 more
europepmc +1 more source

